991
Views
27
CrossRef citations to date
0
Altmetric
Autophagic Punctum

Autophagic proteins

New facets of the oxygen paradox

, , &
Pages 426-428 | Published online: 03 Feb 2012

Figures & data

Figure 1. Schematic of the proposed pathways. Hyperoxia increases cellular reactive oxygen species (ROS) production which promotes the expression and activation of LC3B, through a pathway dependent on c-Jun-NH2-terminal kinase (JNK). We describe dynamic interactions between LC3B and the apoptotic regulator Fas. The interactions of LC3B and Fas depend on phospho-caveolin-1. LC3B provides transient cytoprotection against hyperoxia by sequestering Fas. This association precludes formation of the death-inducing signaling complex (DISC), which consists of Fas, Fas-associated death domain protein (FADD) and caspase-8. The balance between LC3B-cav-1-Fas complex formation determines cell fate.

Figure 1. Schematic of the proposed pathways. Hyperoxia increases cellular reactive oxygen species (ROS) production which promotes the expression and activation of LC3B, through a pathway dependent on c-Jun-NH2-terminal kinase (JNK). We describe dynamic interactions between LC3B and the apoptotic regulator Fas. The interactions of LC3B and Fas depend on phospho-caveolin-1. LC3B provides transient cytoprotection against hyperoxia by sequestering Fas. This association precludes formation of the death-inducing signaling complex (DISC), which consists of Fas, Fas-associated death domain protein (FADD) and caspase-8. The balance between LC3B-cav-1-Fas complex formation determines cell fate.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.